Insight

Filippo Alongi

Jun 18, 2025, 15:32

Filippo Alongi Shared Study on Real-World Safety and Feasibility of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients

Filippo Alongi, Professor at University of Brescia, shared a post on X about his recent article, published in Cancers Journal:

“Our experience of optimal feasibility and no significant toxicity with 1.5 T MR-guided daily adapted RT in 1000 cases is now available in detail here.”

Title: The Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center

Journal: Cancers

Authors: Chiara De-Colle, Michele Rigo, Andrea Gaetano Allegra, Luca Nicosia, Niccolò Giaj-Levra, Edoardo Pastorello, Francesco Ricchetti, Carolina Orsatti, Andrea Romei, Nicola Bianchi, Riccardo Filippo Borgese, Antonio De Simone, Davide Gurrera, Stefania Naccarato, Gianluisa Sicignano, Ruggero Ruggieri, Filippo Alongi

Read the full article.

Filippo Alongi

More posts featuring Filippo Alongi on OncoDaily.

Andrea Gaetano Allegra Andrea Romei Antonio De Simone cancer Cancers Journal Carolina Orsatti Chiara De-Colle Davide Gurrera Edoardo Pastorello Filippo Alongi Francesco Ricchetti Gianluisa Sicignano Luca Nicosia Michele Rigo Niccolò Giaj Levra Nicola Bianchi OncoDaily Oncology Riccardo Filippo Borgese Ruggero Ruggieri Stefania Naccarato University of Brescia

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers